Notably, the combination of small-molecule inhibitors of β-catenin or FAK along with vemurafenib not only inhibits the proliferation of BRAF V600E colon cancer cells in vitro but also prevents tumor formation in xenograft mice [148]. Here, PTK2 is linked to neoplasm.